Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Operating Expenses
General and administrative	$ 447,208	$ 337,992
Research and development	450,910	318,743
Professional fees	526,427	1,915,383
Total Operating Expenses	1,424,545	2,572,118
Total Operating Loss	(1,424,545)	(2,572,118)
Other Income	47,724	78,341
Net Loss	(1,376,821)	(2,493,777)
Net loss attributable to non-controlling interests	(2,488)	(14,625)
Net Loss attributable to CQENS Technologies, Inc.	$ (1,374,333)	$ (2,479,152)
Basic loss per common share	$ (0.05)	$ (0.09)
Diluted loss per common share	$ (0.05)	$ (0.09)
Basic weighted average shares outstanding	27,575,952	27,060,695
Diluted weighted average shares outstanding	27,575,952	27,060,695
Comprehensive Loss:
Change in foreign currency translation adjustments	$ (9,273)	$ 42
Comprehensive Loss:	(1,386,094)	(2,493,735)
Comprehensive loss attributable to non-controlling interests	(5,953)	(14,604)
Comprehensive loss attributable to CQENS Technologies, Inc.	$ (1,380,141)	$ (2,479,131)